Replimune Group, Inc.

REPLNASDAQHealthcare● Active

$8.98

$-0.50(-5.23%)

Market Cap$741089256

P/E Ratio—

52W High$13.24

52W Low$1.5

Avg Volume7.3M

Open$9.20

Beta0.91

Cash on Hand Financials Revenue

Replimune Group, Inc. (REPL) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

REPL · cash on hand · updated Mar 31, 2025

Core cash position

as of Mar 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$483.8M▲ +15.0% vs prior year

FY · as of Mar 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$111.1M

cashAndCashEquivalents

Short-Term Investments

$372.7M

shortTermInvestments

YoY Change vs Prior Year

+15.0%

vs prior fiscal year

Latest Quarter

$269.1M

Q4 2025

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: March 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$483.8MCash on Hand

Total Debt$76.2MTotal Debt

Net Cash / Net Debt+$407.6MNet Cash Position

Cash vs Debt Ratio

Cash 86%Replimune Group, Inc. cash as % of market cap: 65.28%% · MCap $1BDebt 14%

Replimune Group, Inc. has a net cash position of $407.6M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$483.8M − $76.2M = +$407.6M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

REPL annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

REPL cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Mar 31, 2025LatestFY$483.8M+15.0%

Mar 31, 2024FY$420.7M-27.9%

Mar 31, 2023FY$583.4M+47.4%

Mar 31, 2022FY$395.7M-16.9%

Mar 31, 2021FY$476.3M+182.6%

REPL cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

REPL vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Replimune Group, Inc.YOU

REPL

$483.8M$728M66.5%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Replimune Group, Inc. (REPL) cash on hand as of March 31, 2025 is $483.8M, comprising $111.1M in cash and cash equivalents (CCE) plus $372.7M in short-term investments — reported as Replimune Group, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Replimune Group, Inc. cash reserves or cash position.

Replimune Group, Inc. annual cash on hand history shows increased +15.0% in 2025: increased +15.0% in 2025. Replimune Group, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Replimune Group, Inc. carries total debt of $76.2M against cash of $483.8M, resulting in a net cash position of +$407.6M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

REPL cash on hand · 5 questions

As of March 31, 2025, Replimune Group, Inc. (REPL) has $483,804,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $111,119,000 in cash and cash equivalents (CCE) plus $372,685,000 in short-term investments. Latest quarter (December 31, 2025): $269,137,000. Data sourced from the annual 10-K filing via FMP.

REPL cash on handREPL cash reservesREPL cash 2025how much cash does REPL have

▸ Source: FMP /balance-sheet-statement · US GAAP · Replimune Group, Inc. · Replimune Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: March 31, 2025